Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 30;15:7279–7295. doi: 10.2147/IJN.S255477

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Zhao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Immunohistological staining of positive expression of BMP-2 (A) and VEGF (C) after PS, PMC, and PMWC implanted in vivo for 4, 8 and 12 weeks. Brown staining indicates positive expression of BMP-2 and VEGF. Quantitative analysis of the positive expression of BMP-2 (B) and VEGF (D) by histological sections after PS, PMC, and PMWC implanted in vivo for 4, 8, and 12 weeks. *p<0.05 and **p<0.01 relative to PS.

Abbreviations: BMP-2, bone morphogenetic protein-2; VEGF, vascular endothelial growth factor; PS, polybutylene succinate; PMC, polybutylene succinate-magnesium phosphate composite scaffolds; PMWC, polybutylene succinate-magnesium phosphate-wheat protein composite scaffolds.